Zobrazeno 1 - 10
of 25
pro vyhledávání: '"S.A. Danilenko"'
Autor:
A.S. Nikitina, E.I. Sharova, S.A. Danilenko, O.V. Selezneva, T.B. Butusova, A.O. Vasiliev, A.V. Govorov, E.A. Prilepskaya, D.Y. Pushkar, E.S. Kostryukova
Publikováno v:
Data in Brief, Vol 10, Iss C, Pp 369-372 (2017)
Current prostate cancer (PCa) diagnostic tests suffer from insufficient sensitivity and specificity. Novel biomarkers that can be detected by minimally invasive methods are of a particular value. Here we provide two datasets. The first one is on the
Externí odkaz:
https://doaj.org/article/e8aa72ceca8c4b579aa17ceda001f819
Autor:
A.S. Nikitina, E.I. Sharova, S.A. Danilenko, O.V. Selezneva, L.O. Skorodumova, A.V. Kanygina, K.A. Babalyan, A.O. Vasiliev, A.V. Govorov, E.A. Prilepskaya, D.Y. Pushkar, E.S. Kostryukova, E.V. Generozov
Publikováno v:
Data in Brief, Vol 25, Iss , Pp - (2019)
Prostate cancer (PCa) is the most frequently diagnosed among men malignant disease that remains poorly characterized at the molecular level. Advanced PCa is not curable, and the current treatment methods can only increase the life expectancy by sever
Externí odkaz:
https://doaj.org/article/84738dedffb14a449032081da944e79f
Publikováno v:
Transbaikalian Medical Bulletin. :122-136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8487bb745f94b86b3e1aa381572fa810
https://doi.org/10.52485/19986173_2023_1_122
https://doi.org/10.52485/19986173_2023_1_122
Autor:
Yu.Yu. Khizhnyak Khizhnyak, S.A. Danilenko Danilenko, M.F. Kinyaykin Kinyaykin, I.V. Naumova Naumova, City Outpatient Clinic № , Yuzhno-Sakhalinsk, Russia
Publikováno v:
Pharmateca. :58-64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa055b2a88db2d2642c3a2947be9ad0a
https://doi.org/10.18565/pharmateca.2020.5.58-64
https://doi.org/10.18565/pharmateca.2020.5.58-64
Publikováno v:
Transbaikalian Medical Bulletin. :9-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e38287711a6e42f3a3a720413079d721
https://doi.org/10.52485/19986173_2019_2_9
https://doi.org/10.52485/19986173_2019_2_9
Autor:
Alexander Govorov, R. Sultanov, E. A. Prilepskaya, E. I. Sharova, Andrey K. Larin, S.A. Danilenko, A. O. Vasiliev, L O Skorodumova, Dmitry Pushkar, K. A. Babalyan, Edward V. Generozov, Elena S. Kostryukova
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 11:194-201
There is a clear need in molecular markers of prostate cancer (PC) that would specify stratification of patients into risk categories and serve as additional parameters to clinical prognostic factors. Altered DNA methylation status is one of molecula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26163c6096663637c9c1da669381a115
https://doi.org/10.1134/s199075081702007x
https://doi.org/10.1134/s199075081702007x
Autor:
S.A. Danilenko, A. O. Vasiliev, O.V. Selezneva, E. A. Prilepskaya, Alexander Govorov, E. I. Sharova, Anastasia S. Nikitina, Dmitry Pushkar, T.B. Butusova, Elena S. Kostryukova
Publikováno v:
Data in Brief
Data in Brief, Vol 10, Iss C, Pp 369-372 (2017)
Data in Brief, Vol 10, Iss C, Pp 369-372 (2017)
Current prostate cancer (PCa) diagnostic tests suffer from insufficient sensitivity and specificity. Novel biomarkers that can be detected by minimally invasive methods are of a particular value. Here we provide two datasets. The first one is on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7af67fe17c31a026f76aaf29edb7cc86
https://doi.org/10.1016/j.dib.2016.12.016
https://doi.org/10.1016/j.dib.2016.12.016
Autor:
B. E. Malyugin, O.P. Antonova, S.A. Danilenko, O.V. Selezneva, E. I. Sharova, Liubov O. Skorodumova, Elena S. Kostryukova
Publikováno v:
Офтальмохирургия, Vol 0, Iss 4, Pp 44-50 (2017)
Purpose. To assess the frequency of the marker alleles at single polymorphisms rs613872, rs17595731 and CTG18.1 trinucleotide repeat expansion in Russian patients with Fuchs’ endothelial corneal dystrophy (FECD).Material and methods. This study inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5af8903d4288118b10f047a7a42e004
https://www.ophthalmosurgery.ru/jour/article/view/294
https://www.ophthalmosurgery.ru/jour/article/view/294
Autor:
S.A. Danilenko, Anastasia S. Nikitina, K.A. Babalyan, Liubov O. Skorodumova, E. A. Prilepskaya, E. I. Sharova, Dmitry Pushkar, A. O. Vasiliev, O.V. Selezneva, Alexandra V. Kanygina, Alexander Govorov, E. S. Kostryukova, Edward V. Generozov
Publikováno v:
Data in Brief, Vol 25, Iss, Pp-(2019)
Prostate cancer (PCa) is the most frequently diagnosed among men malignant disease that remains poorly characterized at the molecular level. Advanced PCa is not curable, and the current treatment methods can only increase the life expectancy by sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043d060491f2962dfa32b67563bb9c7d
https://pubmed.ncbi.nlm.nih.gov/31223638
https://pubmed.ncbi.nlm.nih.gov/31223638
Autor:
E. A. Prilepskaya, E. I. Sharova, Anastasia S. Nikitina, S.A. Danilenko, V. V. Babenko, O.V. Selezneva, K. A. Babalyan, A. O. Vasiliev, Alexander Govorov
Publikováno v:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 10:180-183
Applicability of prostate cancer candidate RNA biomarkers screening in plasma and urine obtained by minimally invasive or noninvasive methods has been demonstrated. In patients with benign prostatic hyperplasia (BPH) significant amounts of RNAs known
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdec7bbf6cc0fd2031271493ee020046
https://doi.org/10.1134/s1990750816020074
https://doi.org/10.1134/s1990750816020074